These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33504879)

  • 21. ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling.
    Yu S; Zhang M; Huang L; Ma Z; Gong X; Liu W; Zhang J; Chen L; Yu Z; Zhao W; Liu Y
    Aging (Albany NY); 2019 Dec; 11(24):12295-12314. PubMed ID: 31848326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rho GEFs and GAPs: emerging integrators of extracellular matrix signaling.
    Kutys ML; Yamada KM
    Small GTPases; 2015; 6(1):16-9. PubMed ID: 25862162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel YAP1 Activator, Identified by Transcription-Based Functional Screen, Limits Multiple Myeloma Growth.
    Maruyama J; Inami K; Michishita F; Jiang X; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Miyamura N; Hirayama J; Nishina H; Nogawa D; Yamamoto K; Hata Y
    Mol Cancer Res; 2018 Feb; 16(2):197-211. PubMed ID: 29061667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and leukemia-associated RhoGEF.
    Nakamura S; Kreutz B; Tanabe S; Suzuki N; Kozasa T
    Mol Pharmacol; 2004 Oct; 66(4):1029-34. PubMed ID: 15258251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho regulation: DLC proteins in space and time.
    Braun AC; Olayioye MA
    Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
    Li YW; Guo J; Shen H; Li J; Yang N; Frangou C; Wilson KE; Zhang Y; Mussell AL; Sudol M; Farooq A; Qu J; Zhang J
    Cell Cycle; 2016 Sep; 15(18):2497-505. PubMed ID: 27428284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs).
    Yamada T; Ohoka Y; Kogo M; Inagaki S
    J Biol Chem; 2005 May; 280(19):19358-63. PubMed ID: 15755723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
    Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
    Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filling GAPs in our knowledge: ARHGAP11A and RACGAP1 act as oncogenes in basal-like breast cancers.
    Lawson CD; Der CJ
    Small GTPases; 2018 Jul; 9(4):290-296. PubMed ID: 27657701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN.
    Guo L; Chen Y; Luo J; Zheng J; Shao G
    FEBS Open Bio; 2019 Mar; 9(3):437-445. PubMed ID: 30868052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A screening-compatible live cell fluorescence resonance energy transfer-based assay for modulation of Rho GTPase activity.
    Müller PM; Rocks O
    STAR Protoc; 2022 Dec; 3(4):101705. PubMed ID: 36149795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
    Lin C; Xu X
    Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms for spatiotemporal regulation of Rho-GTPase signaling at synapses.
    Duman JG; Mulherkar S; Tu YK; X Cheng J; Tolias KF
    Neurosci Lett; 2015 Aug; 601():4-10. PubMed ID: 26003445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.
    Vlahov N; Scrace S; Soto MS; Grawenda AM; Bradley L; Pankova D; Papaspyropoulos A; Yee KS; Buffa F; Goding CR; Timpson P; Sibson N; O'Neill E
    Curr Biol; 2015 Dec; 25(23):3019-34. PubMed ID: 26549256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.
    Ben C; Wu X; Takahashi-Kanemitsu A; Knight CT; Hayashi T; Hatakeyama M
    J Biol Chem; 2020 Oct; 295(41):13965-13980. PubMed ID: 32763976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat.
    Jia Z; Johnson AC; Wang X; Guo Z; Dreisbach AW; Lewin JR; Kyle PB; Garrett MR
    PLoS One; 2015; 10(7):e0132553. PubMed ID: 26172442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
    Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
    Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DBS is activated by EPHB2/SRC signaling-mediated tyrosine phosphorylation in HEK293 cells.
    Nakano S; Nishikawa M; Asaoka R; Ishikawa N; Ohwaki C; Sato K; Nagaoka H; Yamakawa H; Nagase T; Ueda H
    Mol Cell Biochem; 2019 Sep; 459(1-2):83-93. PubMed ID: 31089935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of receptor responses induced by prolonged binding of Gα
    Bodmann EL; Krett AL; Bünemann M
    FASEB J; 2017 Aug; 31(8):3663-3676. PubMed ID: 28465324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.